hydroxychloroquine living meta-analysis of clinical studies

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only

	COVID 19 all comers	COVID-19 mild to moderate	COVID-19 severe or critically

	COVID 19 hospitalized	COVID 19 all comers	COVID-19 mild to moderate	COVID-19 severe or critically
hydroxychloroquine	OAHU-COVID19 IRCT20200428047228N1 // U07 Chen CCAP-1 HYCOVID Gonzalez ... NO COVID-19 ... Duke university HCQ HAHPS RECOVERY ARCHAIC -hydroxychloroquine PROTECT A ORCHID Duke University hydroxychloroquine/azithromycine Abd-Elsalam PROTECT B Tang SOLIDARITY ... TEACH	ChiCTR2000030054-HCQ ... IRCT20150808023559N20 IRCT20150808023559N20 NOR-Solidarity ...	Zhaowei Chen Coalition Covid-19 Brazil I ... Dubee NCT04333654 Kamran HC-nCoV ... FACCT Trial	Sarhan REMAP-CAP-HCQ HYDRA ... Sarhan

4887	Gautret et al., 2020	1	31	3		not a RCT	high risk of bias
5267	Mahevas, 2020	1	13	3		not a RCT	high risk of bias
5313	Magagnoli (HC), 2020	1	13	3		not a RCT	high risk of bias
5350	Yu, 2020	1	13	4		not a RCT	high risk of bias
5354	Geleris, 2020	1	13	3		not a RCT	high risk of bias
5368	Novales, 2020	1	13	4		not a RCT	high risk of bias
5478	Paccoud, 2020	1	13	3		not a RCT	high risk of bias
5481	Sbidian (HCQ alone), 2020	1	13	4		not a RCT	high risk of bias
5512	Arshad (HCQ), 2020	1	13	4		not a RCT	high risk of bias
5517	Min, 2020	1	13	0		not a RCT	risk of bias not avaialble
5596	Kalligeros, 2020	0	13	0	selection pending
5762	Belgian Collaborative Group on COVID-19, 2020	1	13	3		not a RCT	high risk of bias
5778	Cravedi, 2020	0	13	0	selection pending
5780	Fontana, 2020	0	13	0	selection pending
5789	Singh, 2020	1	13	4		not a RCT	high risk of bias
6252	NCT04376814-Group A, 2020	0	31	0	selection pending